[1] Wang J, Zhang L, Wang F, et al. Prevalence, awareness,
treatment, and control of hypertension in china: results
from a national survey [J]. American Journal of Hypertension,
2014,27(11):1355-1361.
[2] 中国高血压防治指南修订委员会.中国高血压防治指南2010[J].
中华高血压杂志,2011,19(8):701-743.
[3] 徐晓莉,汤伟民. 坚持政府主导促进全民健康[J]. 慢性病学杂志,
2015(1):6-8.
[4] 亓晓,张普洪,张勇,等.中国慢性病预防控制策略现状[J].中国慢
性病预防与控制,2012,20(2):214-217.
[5] 中国高血压基层管理指南修订委员会.中国高血压基层管理指南
(2014年修订版) [J].中华高血压杂志,2015,23(1):24-43.
[6] 赵秀丽,陈捷,崔艳丽,等.中国14 省市高血压现状的流行病学研
究[J].中华医学杂志,2006,86(116):1148-1152.
[7] Ghembaza MA, Senoussaoui Y, Tani MK, et al. Impact
of patient knowledge of hypertension complications on adherence
to antihypertensive therapy [J]. Curr Hypertens
Rev, 2014,10(1):41-48.
[8] Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/
ESC Practice Guidelines for the Management of Arterial
Hypertension [J]. Blood Press, 2014,23(1):3-16.
[9] James PA, Oparil S, Carter BL, et al. 2014 evidencebased
guideline for the management of high blood pressure
in adults:report from the panel- members appointed to the
Eighth Joint Nation